MetaVia Inc. — Director's Dealing 2024

Aug 13, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2024-08-11

Reporting Person: Kim Hyung Heon (Director, CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-11	Common Stock	F	11467	$3.60	Disposed	66666	Direct

Footnotes

F1: Shares were withheld by the Issuer in satisfaction of the Reporting Person's tax liabilities in connection with the vesting of restricted stock units, based on the Issuer's closing price on August 9, 2024.

F2: The total number of securities beneficially owned has been adjusted to reflect the Issuer's completion of a 1-for-8 reverse stock split on December 20, 2023.